Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1624 1626 1629
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18251111 | CRYSTALLINE FORM IV OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PREPARATION METHOD THEREFOR | Final Rejection | LG CHEM, LTD. |
| 18018207 | ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 18694139 | COMPOSITIONS AND METHODS FOR AMELIORATING MEDICAL CONDITIONS RELATING TO CORONAVIRUS INFECTIONS | Non-Final OA | The Regents of the University of California |
| 18570473 | CHIRAL 3-SULFINYL BENZOIC ACIDS | Non-Final OA | BAYER AKTIENGESELLSCHAFT |
| 17596491 | TARGETING DNA REPAIR IN TUMOR CELLS VIA INHIBITION OF ERCC1-XPF | Final Rejection | The Governors of the University of Alberta |
| 18268102 | METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND STAT3-LINKED CANCERS USING SUPPRESSORS OF ELECTRON LEAK | Final Rejection | Cornell University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy